Founding NICE chairman Sir Mike Rawlins dies at 81
Sir Mike Rawlins (pictured above in 2008), a UK pharmacologist who made a massive impact in the field of medicines reimbursement in his own country and internationally, has died at the age of 81.
The National Institute for Health and Care Excellence (NICE) - the cost-effectiveness watchdog of which Sir Mike was founding chairman - announced his death on Tuesday morning via its Twitter account.
Sir Mike led the NICE from 1999 to 2013 and is credited for taking the agency through its formative years to its current position as a world leader in health and social care guidance and medicine evaluation, the tweet reads.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze